A-Level Capital
VC Fund
Baltimore, United States
A-Level Capital is a VC fund in Baltimore focused on Health Care and Medical. A-Level Capital, LLC is a student-led venture capital fund based in Baltimore, Maryland. Our firm invests in Johns Hopkins University student and young alumni founded companies. Please visit our website, alevelcapital.com to learn more and/or apply for start-up funding.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries A-Level Capital invests in
Stages A-Level Capital invests in
Countries A-Level Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $100k–$4.6M
- Series A
- $2.8M–$6M
- Venture - Series Unknown
- $320k–$500k
Investment Focus
Industry
- Health Care 7 (37%)
- Medical 6 (32%)
- SaaS 5 (26%)
- Internet 4 (21%)
- Software 4 (21%)
Stage
- Seed 13 (68%)
- Venture - Series Unknown 3 (16%)
- Series A 2 (11%)
Country
- United States 17 (89%)
- Hong Kong 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Silveth Khawaja
Advisory Board/Investment Committee Member
|
Advisory Board/Investment Committee Member | Total investments: 0 | Find email | |
Corey Li
Founding Partner, Co-Founder
|
Founding Partner, Co-Founder | Total investments: 0 | Find email | |
Demilade Obayomi
Co-Founder & Investor
|
Co-Founder & Investor | Total investments: 0 | Find email | |
Ron Schmelzer
Investor / Investment Committee Member
|
Investor / Investment Committee Member | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| We help evolve the community experience for HR, CRE, and Unions providing a single interoperable SAAS platform to organize, integrate, and communicate an employers ever-expanding health and benefits offerings.The product is modular, customizable, and data driven. Built for HR and management teams that want to provide a omni-channel employeecentric experience.Our set of integrated tools and modules can be combined and tailored to maximize engagement and engagement today reduces cost tomorrow. The platform is composed of a core tool sets of functionality including:Engagement & Onboarding - Forms, Form Flows, Data Aggregation, Polling, Surveys, AnalyticsCommunication Tools - Temporal Feature Content, Scrolling News Feeds, Interactive Scaled Events, Direct MessagingScheduling (Live or Video) - Meetings, Classes, Training, Events eLearning - Wellness, Internal Training, 3rd Party feedsBenefits Admin & Discovery - Insurance, Open Enrollment, 3rd party integrationEmployee Recognition - Challenges, Social Recognition, Rewards/PerksWellness - Live and Digital Classes, Self Care tools, Health Tracker, Health Marketplace We have over 100 corporations working with us currently including groups as diverse as Reddit, New York Transit Authority, First Republic Bank, Silverstein Properties, and Johns Hopkins University. | $1.5M / Seed / Jun 01, 2024 | ||
| Build powerful AI workflows in minutes. | $1.4M / Seed / Jan 09, 2024 | ||
| Founded in 2016 and headquartered in New York City, Order is a guided B2B marketplace with a mission to simplify buying for businesses. Powered by predictive applications and embedded fintech, Order sits at the intersection of a business, their vendors, and their payment methods to deliver tailored solutions up and down the entire buying process.With nearly half a billion in annualized spend, hundreds of finance, operations, and procurement teams – across customers like WeWork, SoulCycle, Lume, and High Level Health – rely on Order to guide their company’s growth. For more information, visit order.co. | $4.6M / Seed / Aug 01, 2018 | ||
| Siren Care is engaging with providers and payers to transform healthcare for chronic disease and aging. Siren significantly improves patient outcomes and experience by augmenting traditional healthcare with tech-enabled clinical models to provide whole person care. Our flagship program, the Siren Diabetic Foot Program, is a comprehensive servicepowered by our proprietary Siren Socks which monitor foot temperature continuously to deliver superior early detection of diabetic foot ulcers. | $100K / Seed / Mar 01, 2017 | ||
| Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases. It pioneered the applications of the generative adversarial networks (GANs), reinforcement learning, transfer learning, and meta-learning for the generation of novel molecular structures for the diseases with known and unknown targets, and,unlike the other companies in the field, is developing the end-to-end pipeline covering every step of drug discovery, clinical trials analysis, and digital medicine. Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with Life Extension, the company launched a range of nutraceutical products, which were compounded using advanced bioinformatics techniques and deep learning approaches. It also provides a range of consumer-facing applications including Young.AI. | $2.8M / Series A / Feb 27, 2017 | ||
| Mindshare Medical is focused on the development of evidence-based clinical decision support technology solutions. The company’s proprietary solution provides personalized diagnostics and guidance on the effectiveness of follow-up procedures and treatments. This approach is intended to improve quality of patient care and reduce financial liabilityfor healthcare organizations.Mindshare Medical was founded by Samir Chowdhury and Michael Calhoun in May 2014. | Venture - Series Unknown / Dec 31, 2016 | ||
| The name Tueo ("too-ee-oh") comes from a Latin word meaning to observe, care for, and maintain. Tueo Health is creating a solution that puts this meaning to work in asthma management. The solution delivers accurate, objective indicators of asthma control together with clinical insight and understanding of what patients and their familiesneed to achieve the best control and outcomes. | Seed / Nov 01, 2016 | ||
| Progressly is a cloud-based Operational Performance Management solution that helps its customers transform their operations. It helps companies move their business from paper to digital. The way most companies get work done today is broken. Some still use manual or paper-based processes, or employ difficult-to-maintain on-premise solutions thatrequire technical administrators. That’s where Progressly comes in. By going paperless with Progressly, you’re not only making your company more efficient, you’re making it smarter. Our platform unifies people, processes, and performance, centralizing work for easy collaboration so you can increase transparency, lower operational costs, and improve information security. Leading brands such as Comcast, Shell, Valero, and others rely on Progressly. For more information, please visit us at www.progressly.com. | $6M / Series A / Sep 20, 2016 | ||
| GiveCampus is a fundraising platform for nonprofit educational institutions. GiveCampus's purpose is to increase the quality, affordability, and accessibility of education. They are trusted by more than 1,000 colleges, institutions, and K–12 schools and offer software, services, and knowledge that enable schools to increase revenue from alarger number of donors at a fraction of the price of alternative fundraising strategies. | Seed / Aug 31, 2016 | ||
| Proscia is a software company that is changing the way the world practices pathology to transform cancer research and diagnosis. With the company’s Concentriq digital pathology platform and pipeline of AI-powered applications, laboratories are leveraging new kinds of data to accelerate discoveries and improve patient outcomes. Proscia’s team oftechnologists, scientists, and pathologists is bringing a fresh approach to an outdated industry, helping the world to keep pace with the increasing demand for pathology services and fulfill the promise of precision diagnostics. | $2M / Seed / Jul 05, 2016 | ||
| See all 19 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does A-Level Capital invest in?
A-Level Capital invests primarily in Health Care, Medical and SaaS startups, most often at Seed and Venture - Series Unknown stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does A-Level Capital invest in?
A-Level Capital typically joins rounds of $100k–$4.6M at Seed, $2.8M–$6M at Series A and $320k–$500k at Venture - Series Unknown. These are whole funding-round sizes, not A-Level Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds A-Level Capital took part in.
How do I contact A-Level Capital?
Public channels for A-Level Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at A-Level Capital?
The team at A-Level Capital includes Silveth Khawaja (Advisory Board/Investment Committee Member), Corey Li (Founding Partner, Co-Founder) and Demilade Obayomi (Co-Founder & Investor). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
